Blair and Milburn braced for foundation trust backlash

October 28, 2003
NHS

 The Government’s controversial plans to introduce foundation hospitals are on a knife-edge ahead of a Commons vote on the reform …

OTC omeprazole to become Glaxo’s next generation Zantac

October 28, 2003
Sales and Marketing

GlaxoSmithKline is poised to launch omeprazole, AstraZeneca's former prescription-only blockbuster Losec as part of its leading over the counter Zantac …

Sanofi upgrades expectations for 2003

October 28, 2003
Sales and Marketing

Sanofi-Synthelabo has upgraded its full-year share earnings guidance for 2003, despite its plans to spend more on R&D.In the first …

Concerns over expansion of fast track surgery

October 28, 2003

Doctors and health unions have expressed their concerns about the effect of new fast track surgery centres on the rest …

GlaxoSmithKline slashes AIDS drug prices

October 28, 2003
Sales and Marketing

GlaxoSmithKline has cut prices of its HIV/AIDS drugs for developing countries by nearly half following intense pressure from campaigners and …

International performance keeps BMS afloat

October 28, 2003
Sales and Marketing

International sales of several key drugs helped Bristol-Myers Squibb to minimise the effects of continued US generic competition in the …

Government proposes ‘clinical exceptions’ to A&E targets

October 28, 2003

The Government is to modify one of its key waiting times targets after sustained protests about its inability to reflect …

Money Syner buy-out to create UK’s biggest healthcare agency

October 28, 2003

Global healthcare communications agency Euro RSCG Life has acquired Money Syner Communications to create what it says will be the …

Pfizer spots potential of Organon atypical antipsychotic

October 28, 2003

Pfizer is  to co-develop and promote a promising new atypical antipsychotic discovered by Dutch pharma company Organon.Under the terms of …

Swiss pharma companies beat expecations

October 28, 2003

Switzerland's number one pharmaceutical company Novartis has reported a sharp rise in sales in the first nine months of the …

Atypical anti-psychotics to get diabetes warning in US

October 28, 2003

All atypical anti-psychotic drugs are to carry warnings on their US labels about potentially fatal hyperglycaemia side-effects and increased risk …

Job cuts at Merck

October 28, 2003

US pharma giant Merck is to make 4,400 redundancies in an effort to stem falling profits, following a 7% drop …

The Gateway to Local Adoption Series

Latest content